Article

Germline BRCA, Chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer

2020-02-25

Abstract excerpt

<title>Abstract</title> <p>Background To analyze the effects of BRCA1/2 mutations on chemotherapy response scores (CRS) and survival in a cohort of patients with advanced-stage ovarian cancer who were treated with neoadjuvant chemotherapy (NAC) followed by interval debulking surgery (IDS). Methods We retrospectively reviewed the medical records of 169 high-grade serous ovarian cancer patients who underwent a g...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 61b6583d-3320-51ca-a2c2-616b6aad8163
DOI: 10.21203/rs.2.17498/v4

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Germline BRCA, Chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancerDOI 10.21203/rs.2.17498/v4Read

Effects of neoadjuvant chemotherapy in ovarian cancer patients with different germline BRCA1/2 mutational status: A retrospective studySemantic proximity Read

Prevalence and clinical characterization of BRCA1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer.Semantic proximity Read

Pathologic chemotherapy response score in epithelial ovarian cancer: Surgical, genetic, and survival considerations.Semantic proximity Read

The Impact of BRCA Mutation on the Efficacy of Neoadjuvant Chemotherapy in Advanced Ovarian Cancer.Semantic proximity Read

Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancerSemantic proximity Read

Chemotherapy response score no longer predicts survival outcomes in high-grade serous ovarian cancer patients with BRCA mutation and/or maintenance therapy.Semantic proximity Read

Prognostic Significance of Clinical Factors Including BRCA Mutation in Epithelial Ovarian, Peritoneal, Fallopian Tube Cancer.Semantic proximity Read

BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patients.Semantic proximity Read

The clinical features associated with mutated BRCA1 and 2 genes in ovarian cancer patients.Semantic proximity Read

Study finds different treatment responses between BRCA2- and BRCA1-mutated ovarian cancers.Semantic proximity Read

"BRCAness" syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations.Semantic proximity Read

Association of BRCA1/2 mutations with prognosis and surgical cytoreduction outcomes in ovarian cancer patients: An updated meta-analysis.Semantic proximity Read